Dominant Drusen, also known as Doyne Honeycomb Retinal Dystrophy, is fundamentally a genetic condition. Understanding its genetic basis is crucial for patients and their families, as it explains how the disease develops and how it is passed from one generation to the next.
The condition is caused by a specific mutation in the EFEMP1 gene, located on chromosome 2. This gene is responsible for producing a protein that forms part of the extracellular matrix—a supportive network that surrounds cells in various tissues, including the retina. The mutation, known as R345W, causes the protein to misfold. Instead of functioning normally, this abnormal protein accumulates beneath the retinal pigment epithelium (RPE), leading to the formation of the characteristic drusen deposits that disrupt vision over time.
Dominant Drusen follows an autosomal dominant pattern of inheritance. "Autosomal" means the mutated gene is located on one of the non-sex chromosomes, meaning the condition affects men and women equally. "Dominant" means that only one copy of the mutated gene—inherited from either the mother or the father—is sufficient to cause the disorder.
Because of this inheritance pattern, if one parent has Dominant Drusen, each of their children has a 50% chance of inheriting the mutated gene and developing the condition. Conversely, there is also a 50% chance that a child will inherit the normal copy of the gene, meaning they will not develop the disease and cannot pass it on to their future children.
For families affected by Dominant Drusen, genetic testing and counseling are highly recommended. A simple blood or saliva test can confirm the presence of the EFEMP1 mutation, providing a definitive diagnosis. This is particularly useful because the early stages of the disease can sometimes be mistaken for other macular conditions.
Genetic counselors play a vital role in helping families navigate this diagnosis. They can explain the inheritance risks in detail, discuss the implications for family planning, and provide emotional support. Furthermore, having a confirmed genetic diagnosis may open doors to participating in future clinical trials targeted specifically at the EFEMP1 mutation.
If you have a family history of early-onset drusen or unexplained vision loss, consult your healthcare provider or an ophthalmologist about the possibility of genetic testing and referral to a genetic counselor.